|
Geographic
Clustering of P. carinii Pneumonia: The Case for Person-to-Person
Transmission [Morris AM, et al. Am J Respir Crit Care
Med 2000;162:1622]: posted 11/30/2000
Duration
of Viral Suppression in Patients on Stable Therapy for HIV-1 Infections
is Predicted by Plasma HIV RNA Level After 1 Month of Treatment
[Maggiolo F, et al. JAIDS 2000;25:36]
posted 11/30/2000
FDA
approved a once-daily new formulation of ddI
posted 11/17/2000
Randomized
study of saquinavir with ritonavir or nelfinavir together with delavirdine,
adefovir, or both in human immunodeficiency virus-infected adults
with virologic failure on indinavir: AIDS Clinical Trials Group
Study 359 [Gulick RM, et al. JID 2000;182:1375]:
posted 11/17/2000
Combination
therapy with hydroxyurea versus without hydroxyurea as first line
treatment options for antiretroviral-naïve patients [Rodriguez
CG, et al. HIV Clin Trials 2000;1:1]
posted 11/17/2000
Effect
of post-treatment isoniazid on prevention of recurrent tuberculosis
in HIV-1-infected individuals: a randomized trial [Fitzgerald
DW, et al. Lancet 2000;356:1470]
posted 11/17/2000
Mucosal
shedding of human herpesvirus 8 in men [Pauk J, et al. NEJM
2000;343:1369]
posted 11/17/2000
FDA
approves Trizivir November 15, 2000
posted 11/17/2000
Large
Clinical Trial Fails to Show Efficacy of Remune
[Evaluation of HIV-1 Immunogen, an immunologic modifier, administered
to patients infected with HIV having 300 to 549 x 106/L CD4 cell
counts. Kahn JO, et al. JAMA 2000;284:2193]
posted 11/9/2000
Control
of SIV Viremia with DNA Vaccine in Rhesus Monkeys [Barouch
DH, et al. Science 2000;290:486]
posted 11/6/2000
Virologic
Results at 16 Weeks Predict Outcome at One Year [Raboud
JM, et al. JAIDS 2000;24:433]
posted 11/6/2000
The
Problem of Measuring Viral Load with Non-B subtypes of HIV
[Walter EA, et al. CID 2000;31:798]
posted
11/6/2000
Wasting
Despite HAART [Wenke CA, et al. CID 2000;31:803]
posted 11/6/2000
|
back
to news table of contents